Medinol Claims Old Partner Infringes Stent Patents
In an attempt to keep a former partner from sinking its teeth into the $5 billion global coronary stent market, Israel's Medinol Ltd. filed a new legal claim Monday against Boston...To view the full article, register now.
Already a subscriber? Click here to view full article